Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease

American Journal of Managed Care

Volumn 15, Issue 8, 2009, Pages 509-518

  Berger, Ariel ^a   Edelsberg, John ^a   Inglese, Gary W ^b   Bhattacharyya, Samir K ^b   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; FUNCTION TEST; HAZARD RATIO; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEMODIALYSIS; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE; SCORING SYSTEM; STUDENT T TEST; UNITED STATES; WILCOXON SIGNED RANKS TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 69749102703     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. National Institute of Diabetes and Digestive and Kidney Diseases Web site. Kidney failure: choosing a treatment that's right for you. http://kidney.niddk.nih.gov/kudiseases/pubs/pdf/choosingtreatment.pdf. Accessed September 2007.
2. Saxena R. Peritoneal dialysis: a viable renal replacement therapy option [published correction appears in Am J Med Sci. 2005;330(3):110]. Am J Med Sci. 2005;330(1):36-47.
3. National Institute of Diabetes and Digestive and Kidney Diseases Web site. Treatment methods for kidney failure: peritoneal dialysis. http://kidney.niddk.nih.gov/kudiseases/pubs/pdf/peritoneal.pdf. Accessed September 2007.
4. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2007.
5. Hirth RA. The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ. 2007;7(4):301-318.
6. Robbins JD, Kim JJ, Zdon G, Chan WW, Jones J. Resource use and patient care associated with chronic kidney disease in a managed care setting. J Manag Care Pharm. 2003;9(3):238-247.
7. Shih YC. Effect of insurance on prescription drug use by ESRD beneficiaries. Health Care Financ Rev. 1999;20(3):39-54. (Pubitemid 29359539)
8. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002;13(9):2353-2362. (Pubitemid 34925246)
9. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8, pt 2):757-763.
10. Rubin DB, Thomas N. Matching using propensity scores: relating theory to practice. Biometrics. 1996;52(1):249-264. (Pubitemid 26125107)
11. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
12. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54-57.
13. Mehrotra R, Kermah D, Fried L, et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol. 2007;18(10):2781-2788. (Pubitemid 47531206)
14. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health; 2006.
15. Shih YC, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures on end-stage renal disease patients. Kidney Int. 2005;68(1):319-329. (Pubitemid 43181391)
16. Bruns FJ, Seddon P, Saul M, Zeidel ML. The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. J Am Soc Nephrol. 1998;9(5):884-890. (Pubitemid 28209099)
17. Yu AW, Chau KF, Ho YW, Li PK. Development of the "peritoneal dialysis first" model in Hong Kong. Perit Dial Int. 2007;27(suppl 2):S53-S55.
18. Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol. 2007;2(6):1317-1328.
19. Sennfält K, Magnusson M, Carlsson P. Comparison of hemodialysis and peritoneal dialysis: a cost-utility analysis. Perit Dial Int. 2002;22(1):39-47. (Pubitemid 34326578)
20. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611-622. (Pubitemid 34971291)
21. Erek E, Sever MS, Akoglu E, et al. Cost of renal replacement in Turkey. Nephrology (Carlton). 2004;9(1):33-38.
22. Hooi LS, Lim TO, Goh A, et al. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia. Nephrology (Carlton). 2005;10(1):25-32.
23. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE study: Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis. 2002;39(2):324-336.
24. Mehrotra R. The John F. Maher Award Recipient Lecture 2006. The continuum of chronic kidney disease and end-stage renal disease: challenges and opportunities for chronic peritoneal dialysis in the United States. Perit Dial Int. 2007;27(2):125-130.
25. Steinbrook R. Medicare and erythropoietin. N Engl J Med. 2007;356(1):4-6.
26. Shahab I, Khanna R, Nolph KD. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist. Adv Perit Dial. 2006;22:180-185.
27. Blake PG. Peritoneal dialysis in the USA. Perit Dial Int. 2006;26(4):416-418.
28. Mehrotra R. Changing patterns of peritoneal dialysis utilization in the United States. Perit Dial Int. 2007;27(suppl 2):S51-S52. (Pubitemid 350047675)
29. Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005;143(3):174-183. (Pubitemid 41076750)
30. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291(6):697-703.
31. Kutner NG, Zhang R, Bamhart H, Collins AJ. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20(10):2159-2167. (Pubitemid 41510092)
32. Wasserfallen JB, Moinat M, Halabi G, et al. Satisfaction of patients on chronic haemodialysis and peritoneal dialysis. Swiss Med Wkly. 2006;136(13-14):210-217.
33. London R, Solis A, Goldberg GA, Wade S, Ryu S. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis. 2002;40(3):539-548. (Pubitemid 34971283)